PaulScherrerInstitut

@psich_en

Official Account of Switzerland's largest research institute. Latest results, new developments, background information. Also in German:

Villigen PSI
Vrijeme pridruživanja: svibanj 2012.

Tweetovi

Blokirali ste korisnika/cu @psich_en

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @psich_en

  1. 22. sij

    Andreas Adelmann, head of the Laboratory for Scientific Computing and Modelling at talks about its competences in theory, modelling, and high-performance computing.

    Poništi
  2. 20. sij

    "Simulation is, next to theoretical and experimental research, the third pillar of science." Andreas Adelmann, head of the Laboratory for Scientific Computing and Modelling at

    Poništi
  3. 16. sij

    From experiments in the materials and biological sciences to large-scale research facilities: In an interview, Andreas Adelmann reports on simulation and modelling at .

    Poništi
  4. 15. sij

    Imaging with neutrons can provide insights into many things − even the wood of a violin. In this way, researchers have investigated at how well violin varnishes protect instruments from moisture.

    Poništi
  5. 13. sij

    If the varnish on a violin is badly worn, a touch-up is recommended. Otherwise moisture can penetrate the wood − and ruin the instrument. This was shown by studies at .

    Poništi
  6. 9. sij

    Well varnished violins play longer: At , researchers have investigated the effects of different coatings on the wood of a violin.

    Poništi
  7. 30. pro 2019.

    Andreas Adelmann, head of the Laboratory for Scientific Computing and Modelling at talks about its competences in theory, modelling, and high-performance computing.

    Poništi
  8. 27. pro 2019.

    "Simulation is, next to theoretical and experimental research, the third pillar of science." Andreas Adelmann, head of the Laboratory for Scientific Computing and Modelling at

    Poništi
  9. 23. pro 2019.

    From experiments in the materials and biological sciences to large-scale research facilities: In an interview, Andreas Adelmann reports on simulation and modelling at .

    Poništi
  10. 6. pro 2019.

    "The SLS 2.0 upgrade will increase data quality by a factor of thousand for some of the experiments," explains Philip Willmott, SLS 2.0 project leader.

    Poništi
  11. 4. pro 2019.

    «Die Technik und das Ingenieurwesen sind seit der erstmaligen Inbetriebnahme der SLS im Jahr 2001 deutlich weitergekommen», so Terence Garvey, Projektleiter SLS 2.0.

    Poništi
  12. 4. pro 2019.

    "Technology and engineering have progressed significantly since SLS was first commissioned in 2001," says Terence Garvey, SLS 2.0 project leader.

    Poništi
  13. 3. pro 2019.

    The Swiss Light Source SLS has been in operation since 2001. An upgrade will ensure that the facility will continue to meet the needs of researchers for decades to come.

    Poništi
  14. 2. pro 2019.

    Detecting and destroying cancer cells: Drugs produced at provide support to hospitals and are of great interest to Swiss industry.

    Poništi
  15. 30. stu 2019.

    SINQ at , as the starting point for all further steps in radionuclide production, opens up the unique opportunity to carry out the entire research operation in one place.

    Poništi
  16. 28. stu 2019.

    The neutron source SINQ at was built from the start in such a way that it can also be used to produce radionuclides for medical research.

    Poništi
  17. 28. stu 2019.

    Brilliant medicines: Radiopharmaceuticals produced at help hospitals to treat cancer patients and improve their chances of recovery.

    Poništi
  18. 27. stu 2019.

    Today, the Swiss Federal Council elected Christian Rüegg as the new director of . PSI heartily congratulates him on his appointment!

    Poništi
  19. 27. stu 2019.

    Terbium-161 is one of the radionuclides that researchers produce with the help of neutrons. The hope: new therapies against cancer.

    Poništi
  20. 26. stu 2019.

    Christian Rüegg, head of the Research with Neutrons and Muons Division at : "The demand is still very high, because radionuclides open up new treatment options for cancer."

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·